---
title: "Lantern Pharma spins out Open-Medicine AI unit to commercialize multi-agent drug discovery platform"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294685990.md"
description: "Lantern Pharma has spun out Open-Medicine AI (OMAI) as a separate entity to commercialize its withZeta.ai multi-agent drug discovery platform. OMAI received licenses for Lantern's models, data, and assets. This structure supports independent funding and valuation, following Lantern's May financing. Additionally, Lantern established an AI Center of Excellence in Bengaluru in Q1 2026 to scale development alongside its Dallas operations."
datetime: "2026-08-03T11:30:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294685990.md)
  - [en](https://longbridge.com/en/news/294685990.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294685990.md)
generator: "portal-rs"
---

# Lantern Pharma spins out Open-Medicine AI unit to commercialize multi-agent drug discovery platform

-   Lantern Pharma formed Open-Medicine AI as a separate company to commercialize its multi-agent drug-discovery platform previously branded withZeta.ai. \* OMAI received commercial licenses to use Lantern’s withZeta.ai models, data, algorithms, related assets, personnel. \* The structure follows terms set in Lantern’s May registered direct financing, positioning OMAI for independent funding and a separate valuation track. \* Lantern set up an AI Center of Excellence in Bengaluru in Q1 2026, adding to Dallas operations to scale platform development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantern Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608030730BIZWIRE\_USPR\_\_\_\_\_20260803\_BW318492) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [LTRN.US](https://longbridge.com/en/quote/LTRN.US.md)

## Related News & Research

- [Has AI made S&P 500 index funds too dangerous to touch?](https://longbridge.com/en/news/298444482.md)
- [How Meta tried, and failed, to grab its employees' data for AI](https://longbridge.com/en/news/298706095.md)
- [Anthropic's AI fluency chief says the best AI users know when to do the work themselves](https://longbridge.com/en/news/298433044.md)
- [Alipay: Agentic AI Purchasing Task Vol. Leaps 7x in Past 5 Mths, to Launch AI Wallet Agent](https://longbridge.com/en/news/298677851.md)
- [Albacross-backed Green AI launches 360-degree AI factory energy audit service](https://longbridge.com/en/news/298311301.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**